These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11104869)

  • 21. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era.
    Hohnloser SH; Klingenheben T; Zabel M; Schöpperl M; Mauss O
    J Am Coll Cardiol; 1999 Jun; 33(7):1895-902. PubMed ID: 10362190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term prognostic significance of M mode echocardiography in young men after myocardial infarction.
    Eriksson SV; Caidahl K; Hamsten A; de Faire U; Rehnqvist N; Lindvall K
    Br Heart J; 1995 Aug; 74(2):124-30. PubMed ID: 7546989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography.
    Eur Heart J; 1993 Jan; 14(1):8-17. PubMed ID: 8432297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS).
    Held C; Hjemdahl P; Rehnqvist N; Björkander I; Forslund L; Brodin U; Berglund L; Angelin B
    Atherosclerosis; 1997 Nov; 135(1):109-18. PubMed ID: 9395279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study.
    Copie X; Hnatkova K; Staunton A; Fei L; Camm AJ; Malik M
    J Am Coll Cardiol; 1996 Feb; 27(2):270-6. PubMed ID: 8557893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality and morbidity after coronary artery bypass surgery related to pre-operative left ventricular ejection fraction: a follow-up study.
    Risum O; Nitter-Hauge S; Abdelnoor M; Levorstad K; Arafa O; Svennevig JL
    Eur Heart J; 1996 Jun; 17(6):874-9. PubMed ID: 8781826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
    Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
    JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function.
    Fu GS; Meissner A; Simon R
    Eur Heart J; 1997 Feb; 18(2):281-9. PubMed ID: 9043846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients.
    La Rovere MT; Pinna GD; Maestri R; Mortara A; Capomolla S; Febo O; Ferrari R; Franchini M; Gnemmi M; Opasich C; Riccardi PG; Traversi E; Cobelli F
    Circulation; 2003 Feb; 107(4):565-70. PubMed ID: 12566367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of routine non-invasive tests to predict clinical outcome in stable angina.
    Daly C; Norrie J; Murdoch DL; Ford I; Dargie HJ; Fox K;
    Eur Heart J; 2003 Mar; 24(6):532-40. PubMed ID: 12643886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction.
    Mahmarian JJ; Mahmarian AC; Marks GF; Pratt CM; Verani MS
    J Am Coll Cardiol; 1995 May; 25(6):1333-40. PubMed ID: 7722130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
    Solomon SD; Zelenkofske S; McMurray JJ; Finn PV; Velazquez E; Ertl G; Harsanyi A; Rouleau JL; Maggioni A; Kober L; White H; Van de Werf F; Pieper K; Califf RM; Pfeffer MA;
    N Engl J Med; 2005 Jun; 352(25):2581-8. PubMed ID: 15972864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial.
    Badar AA; Perez-Moreno AC; Hawkins NM; Jhund PS; Brunton AP; Anand IS; McKelvie RS; Komajda M; Zile MR; Carson PE; Gardner RS; Petrie MC; McMurray JJ
    Circ Heart Fail; 2015 Jul; 8(4):717-24. PubMed ID: 26067854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris.
    Thompson SG; Fechtrup C; Squire E; Heyse U; Breithardt G; van de Loo JC; Kienast J
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):357-62. PubMed ID: 8630659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics, aetiological factors and long-term prognosis of myocardial infarction with an absolutely normal coronary angiogram; a 3-year follow-up study of 91 patients.
    Da Costa A; Isaaz K; Faure E; Mourot S; Cerisier A; Lamaud M
    Eur Heart J; 2001 Aug; 22(16):1459-65. PubMed ID: 11482919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
    Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of thrombolysis, coronary artery patency, signal-averaged electrocardiography, left ventricular ejection fraction, and Holter electrocardiographic monitoring for life-threatening ventricular arrhythmias after a first acute myocardial infarction.
    de Chillou C; Sadoul N; Bizeau O; Feldmann L; Gazakuré E; Ismaïl M; Magnin-Poull I; Blankoff I; Aliot E
    Am J Cardiol; 1997 Oct; 80(7):852-8. PubMed ID: 9381997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sudden death among 1,000 patients with myocardial infarction: incidence and contributory factors. KYSMI Study Group].
    Kambara H; Kinoshita M; Nakagawa M; Sakurai T; Kawai C
    J Cardiol; 1995 Feb; 25(2):55-61. PubMed ID: 7897607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cardiovascular risk factor, left ventricular hypertrophy, is highly prevalent in stable, treated angina pectoris.
    Ang DS; Pringle SD; Struthers AD
    Am J Hypertens; 2007 Oct; 20(10):1029-35. PubMed ID: 17903683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restenosis or rapid progression in non-dilated sites are not predictors of late spontaneous coronary events.
    Benchimol D; Dubroca B; Dufourq P; Benchimol H; Couffinhal T; Dartigues JF; Bonnet J
    Int J Cardiol; 1997 Jul; 60(2):201-11. PubMed ID: 9226292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.